Has William Hucker, MD received payments from drug or device companies?

Yes. Drug and device makers reported $24,931 in general payments to William Hucker, MD across 61 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Hucker, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Hucker, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Hucker, MD

Internal Medicine · Boston, MANPI 1316174808

Payments from drug & device makers

$24,931in general payments, 2019–2025

Across 61 payments — averaging $408.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$17K
Boston Scientific$8K
Abbott$531

What the payments were for

Speaking & faculty fees$9,90040%
Grants$5,83323%
Travel & lodging$6,98528%
Food & beverage$2,2139%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	41	$16,742
Boston Scientific	12	$7,658
Abbott	8	$531

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,931 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$362,204

Medicare patients

1,897

Services billed

3,839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	119	$137,852
XareltoRivaroxaban	21	$25,105
MultaqDronedarone Hcl	18	$15,935
Amiodarone Hcl	49	$2,678
Metoprolol Succinate	122	$2,340
Mexiletine Hcl	22	$1,992
SotalolSotalol Hcl	20	$614
Rosuvastatin Calcium	14	$377
Diltiazem 24hr Er (Cd)Diltiazem Hcl	13	$322
Atorvastatin Calcium	14	$300
Carvedilol	29	$265
Furosemide	11	$48
Metoprolol Tartrate	11	$8

Paid to pharmacies, not to this prescriber.

Other internal medicine in Boston

Noopur RajeBoston$19.9M
Rebecca HeistBoston$17.4M
Richard PlattBoston$13.5M
Ryan CorcoranBoston$11.4M
Elizabeth LeeBoston$9.8M
Xiuning leBoston$7.9M
Adrienne WaksBoston$7.3M
Ibiayi Dagogo-JackBoston$5.8M
Bilal SiddiquiBoston$5.4M
David SchenkeinBoston$5.2M

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →